Sherbrooke Park Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,501
| Closed | -$393K | – | 715 |
|
|
2025
Q1 | $393K | Sell |
15,501
-34,591
| -69% | -$877K | 0.18% | 204 |
|
|
2024
Q4 | $1.33M | Buy |
+50,092
| New | +$1.33M | 0.42% | 19 |
|
|
2024
Q3 | – | Sell |
-26,269
| Closed | -$735K | – | 1171 |
|
|
2024
Q2 | $735K | Buy |
+26,269
| New | +$735K | 0.13% | 258 |
|
|
2023
Q4 | – | Sell |
-15,935
| Closed | -$529K | – | 627 |
|
|
2023
Q3 | $529K | Sell |
15,935
-65
| -0.4% | -$2.16K | 0.17% | 229 |
|
|
2023
Q2 | $587K | Sell |
16,000
-5,700
| -26% | -$209K | 0.31% | 134 |
|
|
2023
Q1 | $885K | Buy |
+21,700
| New | +$885K | 1.34% | 7 |
|